Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center

Treatment for recurrent intracranial neoplasms is often difficult and less standardized. Since its approval by the Food & Drug Administration (FDA), GammaTile(TM) (GT, GT Medical Technologies, Tempe, AZ), a novel collagen tile cesium brachytherapy, has been investigated for use in this populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Warren, Kwanza T, Boucher, Andrew, Bray, David P, Dresser, Sean, Zhong, Jim, Shu, Hiu-Kuo, Olson, Jeffrey, Hoang, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687694/
https://www.ncbi.nlm.nih.gov/pubmed/34950555
http://dx.doi.org/10.7759/cureus.19777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687694/
https://www.ncbi.nlm.nih.gov/pubmed/34950555
http://dx.doi.org/10.7759/cureus.19777

Ejemplares similares